Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite® Breast Brachytherapy Registry Trial

@article{Goyal2009FactorsAW,
  title={Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite® Breast Brachytherapy Registry Trial},
  author={Sharad Goyal and Atif J. Khan and Frank A. Vicini and Peter D. Beitsch and MS MaureenLyden and Martin E Keisch and Bruce G. Haffty},
  journal={Annals of Surgical Oncology},
  year={2009},
  volume={16},
  pages={2450-2458}
}
To evaluate factors associated with optimal cosmetic results at 36 months for early-stage breast cancer patients enrolled on the American Society of Breast Surgeons (ASBrS) MammoSite® Breast Brachytherapy registry trial. 1,440 patients (1,449 cases) with early-stage breast cancer undergoing breast-conserving therapy were treated with the MammoSite® radiation therapy system (RTS) brachytherapy catheter to deliver adjuvant accelerated partial breast irradiation (APBI) (34 Gy in 3.4-Gy fractions… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Brachytherapy in the treatment of breast cancer

International Journal of Clinical Oncology • 2017

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Surgical treatment of early-stage breast cancer in the Department of Defense Healthcare System

JJ Kelemen, 3rd, T Poulton, MT Swartz, I. Jatoi
J Am Coll Surg • 2001

Similar Papers

Loading similar papers…